Attention!

This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical of pharmaceutical specialist?

Report an adverse reaction
Main pageOur products
Revelise®

Revelise®

INN: alteplase

Description
Indications for use

Recombinant tissue plasminogen activator, a glycoprotein that is activated by binding to fibrin, which causes the conversion of plasminogen to plasmin and leads to the dissolution of the fibrin clot.

Alteplase was included in the “List of strategically important medicines, the production of which must be ensured on the territory of the Russian Federation” (Order of the Government of the Russian Federation dated July 6, 2010 No. 1141-r).

The GENERIUM is the first company in the world that has developed and registered the biosimilar of alteplase - Revelise®

ЛП-05158 от 01.11.2018